TGFB1 and colorectal carcinoma: In addition, RUNX3/MYC/TGF-β1 signaling sustains autocrine TGF-β1 to activate CAFs, while the activated CAFs release miR-17-5p to CRC cells, thus forming a positive feedback loop for exacerbating CRC progression.